86826 Hla x-match noncytotoxc additional
Also known as: Additional non-cytotoxic crossmatch, Extended non-complement XM
Human leukocyte antigen non-cytotoxic cross-match additional testing to evaluate supplementary donor-specific antibodies. Extended evaluation of graft risk.
In Plain Language
Extended graft antibody test
Clinical Context
Performed as add-on testing to comprehensive non-cytotoxic HLA cross-matching. Detects additional donor-specific antibody specificities.
RVU Information
CPT 86826 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 86826?
CPT 86826 (Hla x-match noncytotoxc additional) is a Pathology & Lab code. Human leukocyte antigen non-cytotoxic cross-match additional testing to evaluate supplementary donor-specific antibodies. Extended evaluation of graft risk.
Who uses CPT code 86826?
CPT 86826 is used by Pathology, Immunology, Transplantation. Performed as add-on testing to comprehensive non-cytotoxic HLA cross-matching. Detects additional donor-specific antibody specificities.
When is CPT 86826 used?
Performed as add-on testing to comprehensive non-cytotoxic HLA cross-matching. Detects additional donor-specific antibody specificities.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.